Autism Case Report: Cause and Treatment of “High Opioid Tone” Autism
Open Access
- 24 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychology
Abstract
Introduction: Neurobiological systems engineering models are useful for treating patients. We show a model of “high opioid tone” autism and present a hypothesis about how autism is caused by administration of opioids during childbirth. Main Symptoms: Clinical diagnosis of autism in a 25 year old man was confirmed by a Social Responsiveness Scale (SRS) self-rating of 79, severe, and a Social Communications Questionnaire (SCQ-2) by the patient's father scoring 27. Cold pressor time (CPT) was 190 seconds—unusually long, consonant with the high pain tolerance of autism. Therapeutic Intervention and Outcomes: At naltrexone 50 mg/day SRS fell to 54 and SCQ-−2–9; both non-significant. CPT fell to 28, repeat 39 s. Improved relatedness was experienced ambivalently, understood as feelings never before experienced—causing pain. Non-compliance with naltrexone was followed by cutting open his palm and drinking alcoholically. Transference focused psychotherapy has helped him remain naltrexone—compliant while he works on issues of identity and relatedness. Conclusion: The model suggests studies that could be conducted to both prevent and treat this form of autism.This publication has 18 references indexed in Scilit:
- Fibromyalgia, autism, and opioid addiction as natural and induced disorders of the endogenous opioid hormonal system.2014
- Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawalNeuroscience, 2013
- The role of immune dysfunction in the pathophysiology of autismBrain, Behavior, and Immunity, 2012
- Depression: An Evolutionarily Conserved Mechanism to Terminate Separation Distress? A Review of Aminergic, Peptidergic, and Neural Network PerspectivesNeuropsychoanalysis, 2009
- Just What Lies “Beyond the Pleasure Principle”?Neuropsychoanalysis, 2008
- Brain Systems for the Mediation of Social Separation‐Distress and Social‐Reward Evolutionary Antecedents and Neuropeptide IntermediariesaAnnals of the New York Academy of Sciences, 1997
- Clinical Case Report: Opiate Antagonist and Event-Related Desynchronization in 2 Autistic BoysNeuropsychobiology, 1995
- Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autismAmerican Journal of Psychiatry, 1994
- Naltrexone in Autistic Children: Behavioral Symptoms and Attentional LearningJournal of the American Academy of Child & Adolescent Psychiatry, 1993
- Naltrexone in Autistic Children: An Acute Open Dose Range Tolerance TrialJournal of the American Academy of Child & Adolescent Psychiatry, 1989